Program explainer
The Claude Scientists Program: 10,000 Seats Explained
Anthropic announced 10,000 Claude seats for scientists on August 27, 2026: standard access free, a premium tier at $15 per month with roughly five times the usage, for one year. It is an access program, not a new model and not an autonomous laboratory. Claude Science is still the workbench, and biology and chemistry researchers stay on Opus-class models.
Updated 2026-09-19
Anthropic is offering 10,000 Claude seats to scientists: standard access free, premium at $15 per month, for one year.
What the program actually provides
On August 27, 2026, Anthropic announced an expansion of its support for scientists: 10,000 Claude seats, with standard access free and a premium tier at $15 per month offering roughly five times the usage. The announcement frames the term as one year. Everything below that headline is ordinary Claude access, which is the part most coverage skips.
Treat the seat as a budget line rather than a capability unlock. It lowers the cost of using Claude on research work; it does not change what Claude is allowed to do, how its citations behave, or who is accountable for a published claim. Eligibility rules, the application path, and remaining seat availability are the volatile parts of a finite program, so check the announcement page itself before planning around a seat.
- Seats: 10,000, announced 2026-08-27.
- Standard tier: free for the program term.
- Premium tier: $15 per month, described as about five times the usage.
- Term: one year.
- Anthropic: Expanding support for scientists — Primary announcement. Check it for current eligibility, application details, and seat availability.
What the program is not
A free seat is not a research method, and the most common misreadings of this program are worth naming directly. It is not a new model: program participants use the same generally available lineup as everyone else. It is not an exemption from safeguards: the restrictions on professional biology and drug-development work apply to a program seat exactly as they apply to a paid account.
It is also not an autonomous laboratory. Claude running a tool loop over your files is a different thing from an agent designing and executing its own experiments, and conflating the two is how research teams end up with results nobody can defend. The autonomous-science question is a real one, but it belongs on a different page than a seat-access explainer.
Finally, a seat does not answer your data-governance question. Which plan the seat maps to, whether an institutional agreement governs it, and what retention settings apply are all questions to resolve before any unpublished manuscript, participant record, or sponsor-confidential dataset goes near a chat box.
- Claude Scientist: autonomous experiment agents — Sibling site covering agents that plan and run experiments. This site stays on human-run research workflows.
- Research data privacy and lab policy — Work out plan type, retention, and institutional policy before uploading research material.
Which model a researcher on a seat can actually use
The model question has a domain-dependent answer as of September 2026, and this is the detail that matters most for anyone doing life-sciences work. Claude Fable 5.1, released September 1, 2026, is the most capable generally available model overall. But Fable still blocks professional biology and drug-development work, and since the Opus 5 launch on July 24, 2026, biology-related requests that Fable declines are routed to Opus 5 rather than an older Opus.
The practical consequence: a biologist or chemist on a program seat should plan around Opus 5 as the ceiling for domain work, not Fable 5.1. That is not a downgrade in most research tasks. Opus 5 carries a 1M-token context window, 128K maximum output, adaptive thinking, and a May 2026 knowledge cutoff, which is more than enough for reading corpora and drafting from a locked evidence table.
Outside the restricted domains, the ordinary cost logic applies. Sonnet 5 at $2 per million input tokens and $10 per million output tokens handles high-volume abstract triage well, and that introductory rate became the standard rate rather than rising on September 1, 2026. Haiku 4.5 is cheaper still for mechanical passes, at the cost of a 200K context window. Batch processing is half price, which suits overnight screening runs across thousands of records.
- Fable 5.1 ($10 / $50 per MTok): strongest general model; blocks professional biology and drug development.
- Opus 5 ($5 / $25 per MTok): the generally available research-capable model for biology and chemistry; 1M context, May 2026 cutoff.
- Sonnet 5 ($2 / $10 per MTok): volume triage and extraction; the introductory price is now the standard price.
- Haiku 4.5 ($1 / $5 per MTok): cheapest mechanical passes; 200K context.
- Mythos 5.1: trusted-access only, not part of the 10,000 seats.
- Claude Central: which model to use — Full current-lineup comparison across all use cases, not just research.
- Claude Reports: pricing and benchmark analysis — Cost-per-token analysis and published benchmark caveats.
Claude Science is still the workbench
The scientists announcement did not replace Claude Science; it pointed back at it. Claude Science remains the surface where tool-using scientific work happens, with research-tool integrations and auditable artifact histories, as distinct from asking a chat window for an answer. A program seat is most valuable when the work spans literature, code, data files, and figures rather than a single question.
Separately, Anthropic describes Mythos 5.1 life-sciences trusted access as enrolling its first participants. That is a restricted track with its own review, not something a scientists-program seat includes, and it should not be described as generally available to researchers.
- Choosing between chat, web search, Research, and Claude Science — Mode selection for research tasks, with the model-choice layer.
What to set up in the first week of a seat
The failure mode for free-access programs is enthusiastic first-week usage that leaves no artifact anyone can audit six months later. If the seat is going to produce work that survives review, the scaffolding should exist before the interesting prompts start.
That scaffolding is not elaborate: a written review question with inclusion criteria, searches run in the databases that own the bibliographic record, an evidence table that Claude drafts from rather than adds to, and a notebook that records the prompt, the input set, the output, and the human decision. None of it depends on which model is current, which is precisely why it is worth building during a one-year program term.
- Claude literature review workflow — Scoped question through locked evidence table.
- Auditable Claude research notebook — What to preserve so another human can reconstruct the path from source to sentence.
- Verify Claude citations and sources — A free seat does not change the citation verification burden.
Workflow checklist
- Read the Anthropic announcement for current eligibility, application path, and seat availability.
- Decide whether the free standard tier or the $15 premium tier matches your usage.
- Confirm which plan and contract govern the seat before uploading research material.
- Check whether your domain falls under the biology and chemistry limits and plan around Opus 5 if it does.
- Set up the protocol, evidence table, and notebook before the first substantive session.
- Use Claude Science when the task spans code, data, and figures rather than a single question.
- Record the program term so the workflow survives the end of the free access.
Researcher FAQ
What is the Claude scientists program?
An Anthropic access program announced on August 27, 2026, offering 10,000 Claude seats to scientists for one year: standard access free and a premium tier at $15 per month with roughly five times the usage.
Is the scientists program free?
Standard access is free for the program term. The premium tier costs $15 per month and is described as about five times the usage.
Can I use Claude Fable 5.1 for professional biology or drug-development research?
No. Fable still blocks professional biology and drug-development work, and biology-related requests are routed to Opus 5 instead. Opus 5 is the generally available research-capable model for those domains.
Does a program seat give me Mythos 5.1?
No. Mythos 5.1 life-sciences access is a separate trusted-access track that Anthropic describes as enrolling its first participants. It is not part of the 10,000 seats.
Is this the same as an AI scientist running its own experiments?
No. This is an access program for human-run research work. Autonomous experiment agents are a separate topic covered by claudescientist.com.
Does a free seat change how my research data is handled?
Do not assume so. Confirm which plan, institutional agreement, retention setting, and model-improvement setting apply before putting unpublished, regulated, or confidential material into any Claude surface.
Related workflows
Related free tools